NMDAR-mfLTP requires the coactivation of NMDA and mGluR5 receptors, and Ca2+ release from postsynaptic IP3-sensitive stores. (A) Transiently blocking NMDARs during tetanus (7 cells) inhibited induction of NMDAR-mfLTP. The NMDAR antagonist CPP (5 μM, horizontal bar) was bath applied for 4 min to slices receiving the tetanus (Tet) and also to naïve slices (4 cells) to map the rate of CPP washout. NMDAR-mfLTP in control slices (7 cells) is superimposed for comparison. (B) Representative NMDAR-mediated currents induced by the tetanus under control conditions and in the presence of 5 μM and 20 μM CPP. Note that 5 μM CPP, a competitive antagonist, was insufficient to completely block these currents, whereas 20 μM CPP produced a complete block. (C) Same procedure as in panel (A), but using enough CPP (20 μM) to completely block NMDAR current during the tetanus (5 cells). (D) Summary graph showing that while incomplete blockade of NMDARs (measured as charge transfer) during tetanus application reduced NMDAR-mfLTP only partially, full blockade of NMDARs abolished NMDAR-mfLTP completely. White bars indicate the magnitude of LTP, black bars indicate charge transfer normalized to control conditions (e.g. in the absence of CPP). (E) Activation of mGluR5, but not mGluR1, is required for NMDAR-mfLTP. Summary plot comparing three experimental groups in which the induction tetanus was delivered in the presence of the mGluR5 antagonist MPEP (4 μM, 6 cells), the mGluR1 antagonist CPCCOEt (100 μM, 4 cells), or in interleaved control slices (n = 6 cells). (F) Effects of GDP-βS (2 mM) postsynaptic loading on NMDAR-mfLTP. GDP-βS was allowed to diffuse into CA3 cells (n = 4) at least for 30 minutes before tetanus. For comparison, NMDAR-mfLTP elicited in interleaved control experiments (n = 4) is superimposed. (G) Summary plots showing that bath application of 50 μM DHPG (in the presence of 100 μM CPCCOEt) induced weak LTP of mf NMDAR-EPSCs (Control, 8 cells). In separate set of experiments, this potentiation was occluded by prior induction of NMDAR-mfLTP (after Tet, 6 cells). (H) NMDAR-mfLTP requires Ca2+ release from IP3-sensitive Ca2+ stores. Summary plots comparing the magnitude of NMDAR-mfLTP in hippocampal slices treated with cyclopiazonic acid (CPA, 5 cells) and in interleaved control slices (5 cells). Test hippocampal slices were incubated in 30 μM CPA for at least 30 min before and continuously during recordings. (I) Summary plots showing the effects of the IP3-receptor blocker heparin (2.5 mg/ml) or the ryanodine receptor blocker ruthenium red (RR) (20 μM) on NMDAR-mfLTP. Heparin (5 cells) and RR (4 cells) were added to the recording pipette.